Search

Your search keyword '"Dianzani, Umberto"' showing total 754 results

Search Constraints

Start Over You searched for: Author "Dianzani, Umberto" Remove constraint Author: "Dianzani, Umberto"
754 results on '"Dianzani, Umberto"'

Search Results

303. Interactions between RPS19, mutated in Diamond-Blackfan anemia, and the PIM-1 oncoprotein

304. XXIV World Allergy Congress 2015

307. The Co-Receptor Function of Murine CD41

308. Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation.

309. Research into New Molecular Mechanisms in Thrombotic Diseases Paves the Way for Innovative Therapeutic Approaches.

310. Alendronate-Grafted Nanoemulsions for Bone-Targeted Vincristine Delivery: Preliminary Studies on Cell and Animal Models.

311. The Role of New Morphological Parameters Provided by the BC 6800 Plus Analyzer in the Early Diagnosis of Sepsis.

312. Variations of the UNC13D Gene in Patients with Autoimmune Lymphoproliferative Syndrome.

313. Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation.

314. Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human Naïve CD4+ T cells

315. Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications.

316. A Computational Model for the Release of Bioactive Molecules by the Hydrolytic Degradation of a Functionalized Polyester-Based Scaffold.

317. Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications.

318. Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering.

319. Optimization of an Injectable, Resorbable, Bioactive Cement Able to Release the Anti-Osteoclastogenic Biomolecule ICOS-Fc for the Treatment of Osteoporotic Vertebral Compression Fractures.

320. PI3-Kinase p110α Deficiency Modulates T Cell Homeostasis and Function and Attenuates Experimental Allergic Encephalitis in Mature Mice

323. Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment.

324. Role of endocytosis and trans-endocytosis in ICOS costimulator-induced downmodulation of the ICOS Ligand

325. Electrospun Collagen Scaffold Bio-Functionalized with Recombinant ICOS-Fc: An Advanced Approach to Promote Bone Remodelling.

326. Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review.

327. ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo.

328. Osteopontin binds ICOSL promoting tumor metastasis

329. Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles

330. Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis.

331. Possible involvement of T cell co-stimulation in pustulosis palmaris et plantaris via the induction of inducible co-stimulator in chronic focal infections

332. Inducible T‐cell co‐stimulator (ICOS) and ICOS ligand are novel players in the multiple‐myeloma microenvironment.

333. Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study.

334. Platelets: "multiple choice" effectors in the immune response and their implication in COVID‐19 thromboinflammatory process.

335. Whole-Slide Imaging Allows Pathologists to Work Remotely in Regions with Severe Logistical Constraints Due to Covid-19 Pandemic.

336. Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles.

337. Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma.

338. A double blind randomized experimental study on the use of IgM-enriched polyclonal immunoglobulins in an animal model of pneumonia developing shock.

339. Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia.

340. G protein–coupled receptor 21 in macrophages: An in vitro study.

341. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.

342. Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibility

343. Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1.

344. The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function

345. Association of osteopontin regulatory polymorphisms with systemic sclerosis

346. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis

347. ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution

348. Osteopontin gene haplotypes correlate with multiple sclerosis development and progression

349. Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma.

350. Glutamate modulation of human lymphocyte growth: in vitro studies

Catalog

Books, media, physical & digital resources